Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Recovergenix is a branded topical wellness product marketed by Armourgenix as a menthol-containing hemp complex roll-on gel intended for temporary relief of sore muscles, joint aches, and post-exercise discomfort. Based on publicly available product descriptions, its apparent functional activity is primarily attributable to **menthol**, which produces a cooling counterirritant effect through sensory neuron activation rather than a well-defined disease-modifying pharmaceutical mechanism; the hemp component is presented as a wellness or nutraceutical ingredient rather than as a clearly characterized approved active pharmaceutical ingredient. The available evidence does not support identification of Recovergenix as a specific approved prescription drug or a clearly defined investigational biotech asset, and the exact standardized composition and regulatory status are not well documented in authoritative drug-development sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Recovergenix.